Dates that could move the NIB share price in 2024

NIB shares investors, get out your 2024 diaries…

| More on:
a woman puts a pen to her mouth as she smiles slightly while checking an old book style diary/calendar.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The NIB Holdings Limited (ASX: NHF) share price is up 4.52% today to $7.98 amid many brokers tipping further growth in 2024.

As my Fool colleague Mitch points out, private insurance businesses have surged since the pandemic.

New data from APRA shows 11.81 million Australians have hospital coverage compared to 11.23 million in December 2019.

It seems that many Australians have decided health insurance is worth it amid long waiting lists for elective surgeries and specialist appointments and reduced Medicare bulk billing.

In FY23, NIB lifted its revenue by 10.9% to $3.1 billion and increased its net profit by 42.8% to $191 million. 

What are the brokers saying about the NIB share price?

Top broker Goldman Sachs reckons NIB is a buy and has a 12-month price target of $8.40.

The broker explains:

We are Buy-rated on NHF given: 1) it offers defensive exposure to the private health insurance sector which is experiencing favourable operating trends, 2) claims environment remains low with no immediate indications of a bounce back in claims, 3) DCL provisions to cover a bounce back in claims are proving redundant, 4) significant policyholder give back incentives suggest claiming environment remains well below expectations, 5) strong recovery in non-resident volume post Covid-19 through the return of international students, workers and visitor arrivals.

Citi also just upgraded NIB shares to a buy rating with an $8.35 share price target.

The important dates of 2024 for NIB investors

ASX shares tend to move on the days when important news is announced.

Helpfully, NIB today released its financial calender for 2024.

Here are the important dates in 2024 for NIB investors to note:

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
Healthcare Shares

Why is this ASX 200 pharmaceuticals stock crashing 15% today?

Investors haven't responded positively to a sales update.

Read more »

A little girl with red hair runs excitedly with a rocket strapped to her back, trying to launch.
Share Gainers

This small-cap ASX stock just rocketed 39%. What's doing?

A stock no one has heard of is lighting up trading screens on Wednesday. You might hear this name more…

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Has the CSL share price got further to fall?

ASX experts weigh in on what's next for CSL.

Read more »

Shot of a young scientist using a laptop while conducting research in a laboratory.
Healthcare Shares

2 popular ASX 200 healthcare shares tanking on earnings updates

Let's check out the earnings reports from these two ASX 200 healthcare shares today.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Hoping to bag the record Medibank dividend? Here's what you need to do

Time is running out if you'd like to bank the ASX 200 healthcare stock's largest-ever dividend.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Earnings Results

Nanosonics share price crashes 14% on first-half profit crunch

Investors haven't responded positively to the release of the company's half-year results.

Read more »

Three excited business people cheer around a laptop in the office
Healthcare Shares

Here's why ResMed shares can jump a further 20%

Investors have done very well from this stock recently. The good news is that analysts expect the trend to continue.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Share Gainers

If you'd put $20,000 in this ASX healthcare stock during COVID-19, you'd have $257,000 now

You could have become filthy rich in just 4 years. Just think about that.

Read more »